TrialInternational journal of rheumatic diseases2020

Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis.

Yoshiya Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.